Quick Answer
Apyx Medical Corp reported Long-Term Debt of $34.85 million for fiscal year 2025.
Apyx Medical Corp Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $34.85M | +2.8% |
| 2024 | $33.89M | +2.1% |
| 2023 | $33.19M | — |
| 2022 | $0.00 | — |
| 2018 | $0.00 | -100.0% |
| 2017 | $2.46M | -8.9% |
| 2016 | $2.69M | +1824.3% |
| 2015 | $140.0K | -95.6% |
| 2013 | $3.19M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $34.61M | +2.2% | +0.7% |
| June 30, 2025 | $34.37M | +2.2% | +0.7% |
| March 31, 2025 | $34.13M | +2.2% | +0.7% |
| December 31, 2024 | $33.89M | +2.1% | +0.1% |
| September 30, 2024 | $33.85M | +275.8% | +0.7% |
| June 30, 2024 | $33.63M | — | +0.7% |
| March 31, 2024 | $33.41M | — | +0.7% |
| December 31, 2023 | $33.19M | — | +268.4% |
- Apyx Medical Corp showed an increase of +2.8% in Long-Term Debt compared to the prior fiscal year.
- Over the 2013–2025 period, Apyx Medical Corp’s long-term debt has grown by 994.2% (from $3.19 million to $34.85 million).
- The most recent figure is from Apyx Medical Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: